Featured Research

from universities, journals, and other organizations

Still no clear evidence for health benefits of vitamin D? Experts try to make sense of the data

Date:
April 1, 2014
Source:
BMJ-British Medical Journal
Summary:
Despite a huge number of studies into the role of vitamin D on health, there is still no clear evidence that it has a beneficial effect on many conditions, conclude researchers. A growing body of evidence indicates that vitamin D may reduce risks of a wide range of diseases, including bone mineral disease, multiple sclerosis, autoimmune disorders, cancer and cardiovascular problems. Yet, despite hundreds of trials, the evidence for vitamin D is still being debated.

Despite a huge number of studies into the role of vitamin D on health, there is still no clear evidence that it has a beneficial effect on many conditions, conclude researchers on bmj.com today. They argue that "universal conclusions about its benefits cannot be drawn" and say further studies and better designed trials are needed.

A growing body of evidence indicates that vitamin D may reduce risks of a wide range of diseases, including bone mineral disease, multiple sclerosis, autoimmune disorders, cancer and cardiovascular problems. Yet, despite hundreds of trials, the evidence for vitamin D is still being debated.

Two papers published on bmj.com today attempt to make sense of the existing data.

The first, by researchers based in the UK, Europe and USA, examined data from observational studies and clinical trials (an umbrella review) to summarisze health outcomes associated with vitamin D levels, both naturally circulating and as a result of taking supplements.

Of a remarkable 137 different health outcomes reportedly linked to vitamin D, they found that only 10 had been thoroughly tested in trials, and only one (birth weight -- linked to a mother's vitamin D levels in late pregnancy) had apparently concordant evidence of "benefit."

In other words, the researchers failed to find any convincing evidence of a clear role of vitamin D for any of the outcomes.

Based on this review, they suggest a "probable" association between vitamin D levels and birth weight, dental caries in children, maternal vitamin D levels at term and parathyroid hormone levels in chronic kidney disease patients requiring dialysis, but "further studies and better designed trials are needed to draw further conclusions."

In contrast to previous reports, their results also cast doubt on the effectiveness of vitamin D-only supplementation for osteoporosis and / or prevention of falls. This suggests that vitamin D "might not be as essential as previously thought in maintaining bone mineral density," they write.

Although vitamin D has been extensively studied in relation to a range of outcomes -- and there are some indications that low blood vitamin D levels might be linked to several diseases -- "firm universal conclusions about its benefits cannot be drawn," say the authors.

In the second paper, an international team led by researchers at the University of Cambridge and the Erasmus Medical Centre, analysed the extent to which vitamin D is associated with death from cardiovascular disease, cancer, or other conditions, under various circumstances.

They analysed the results of observational cohort studies and randomized controlled trials of both naturally circulating vitamin D and supplements (given singly as either vitamin D2 or D3 supplements).

They found that low circulating vitamin D levels in blood were associated with increased mortality risks from cardiovascular disease, cancer, and other causes.

Average follow-up in the randomized controlled trials ranged from about 3 to almost 7 years. Among the people who received vitamin D supplements in the trials, there were 2,527 deaths in total, compared to 2,587 events in the control groups. Further analysis of subgroups in the trials showed that, when given alone (i.e. not co-administered with other supplements), vitamin D2 supplements did not seem to reduce the risk of death during follow up. However, in the 14 trials that evaluated vitamin D3 alone, among people taking these supplements the risk of death during follow up was cut by 11%.

However, the authors stress that "further clinical investigations will be essential to establish the optimal dose, duration and safety, and whether vitamin D2 or D3 have different effects on mortality risk, since the available trials are based on elderly populations in general (an age group with high competing risk of death often due to multiple co-existing disease conditions) and they do not typically include cause-specific deaths as the primary outcomes."

In an accompanying editorial, Naveed Sattar and Paul Welsh from the British Heart Foundation Research Centre at Glasgow University, say the apparent degree of benefit from D3 "seems remarkable," but warn that "several limitations must be considered" before these results are taken as a green light for widespread D3 supplementation.

They suggest healthcare professionals treat all observational data cautiously, and call for new trial data "with a focus on potential risks as well as benefits." And they urge clinicians to avoid costly measurement of vitamin D in patients without bone disease related conditions.

"Some may argue that supplementing those who are apparently "deficient" is cheap, but patients may gain false reassurance from prescription of a "protective" tablet, they write. "To improve health and prevent chronic disease, we should stick to what is proven: encourage better lifestyles in general and target established risk factors in people at elevated risk," they conclude.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal References:

  1. E. Theodoratou, I. Tzoulaki, L. Zgaga, J. P. A. Ioannidis. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ, 2014; 348 (apr01 2): g2035 DOI: 10.1136/bmj.g2035
  2. R. Chowdhury, S. Kunutsor, A. Vitezova, C. Oliver-Williams, S. Chowdhury, J. C. Kiefte-de-Jong, H. Khan, C. P. Baena, D. Prabhakaran, M. B. Hoshen, B. S. Feldman, A. Pan, L. Johnson, F. Crowe, F. B. Hu, O. H. Franco. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ, 2014; 348 (apr01 2): g1903 DOI: 10.1136/bmj.g1903

Cite This Page:

BMJ-British Medical Journal. "Still no clear evidence for health benefits of vitamin D? Experts try to make sense of the data." ScienceDaily. ScienceDaily, 1 April 2014. <www.sciencedaily.com/releases/2014/04/140401210404.htm>.
BMJ-British Medical Journal. (2014, April 1). Still no clear evidence for health benefits of vitamin D? Experts try to make sense of the data. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/04/140401210404.htm
BMJ-British Medical Journal. "Still no clear evidence for health benefits of vitamin D? Experts try to make sense of the data." ScienceDaily. www.sciencedaily.com/releases/2014/04/140401210404.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins